Analysis of Safety Issues of Using Statins in Patients with Diabetes and Hypothyroidism

QR Code

Analysis of Safety Issues of Using Statins in Patients with Diabetes and Hypothyroidism

The widespread use of statins in clinical practice necessitates a systematic approach to the risk and safety assessment. The aim of the study was to analyze information about adverse reactions to statins and their specific causes in patients with hypercholesterolemia accompanied by diabetes and hypo...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Arkhipov, G. I. Gorodetskaya, O. A. Demidova, T. V. Alexandrova, A. A. Alexandrov
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2019-12-01
Series:	Безопасность и риск фармакотерапии
Subjects:	statins adverse reactions security applications statin-induced myopathy hyperglycemia diabetes mellitus hypothyroidism
Online Access:	https://www.risksafety.ru/jour/article/view/152
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Statin-Induced Myopathy
by: D. A. Sychev, et al.
Published: (2023-09-01)

Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case)
by: A. V. Melekhov, et al.
Published: (2025-06-01)

THE SLCO1B1 GENE POLYMORPHISM AND STATIN-INDUCED MYOPATHY IN RUSSIAN PATIENTS
by: V. I. Petrov, et al.
Published: (2014-10-01)

Two Cases of Statin-Induced Immune-Mediated Necrotizing Myopathy: A Rare Side Effect of Statins
by: Luis Angel Montero Furelos, et al.
Published: (2025-06-01)

Statin-induced Myonecrosis—A Rare Adverse Effect of a Common Drug: A Case Report
by: Hanna Demissie, et al.
Published: (2025-06-01)

New experimental possibilities for statin myopathy diagnosing
by: E. V. Vinogradova, et al.
Published: (2021-07-01)

Statin safety: myths and reality
by: Zh. D. Kobalava, et al.
Published: (2007-04-01)

STATINS AND MYOPATHY: MOLECULAR MECHANISMS
by: O. M. Drapkina, et al.
Published: (2015-12-01)

MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS
by: A. S. Kazakov, et al.
Published: (2018-09-01)

MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT
by: O. M. Drapkina, et al.
Published: (2015-09-01)

INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: V. I. Petrov, et al.
Published: (2015-09-01)

Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre
by: E. O. Kochkina, et al.
Published: (2023-09-01)

Rheumatic manifestations of hypothyroidism
by: L. V. Teplova, et al.
Published: (2017-04-01)

STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015-09-01)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01)

STATIN ADVERSE EFFECTS: MECHANISMS, DIAGNOSIS, PREVENTION AND MANAGEMENT
by: A. I. Dyadyk, et al.
Published: (2018-08-01)

Establishment and validation of a risk prediction model for adverse drug reactions in patients with coronary heart disease after taking statins: a retrospective study
by: Lixiang Zhang, et al.
Published: (2025-07-01)

Effect of Statins (Zocor) on Oxygen-Dependent Processes in Muscle Tissue and Erythrocytes in Animals with Hypercholesterolemia
by: E. V. Vinogradova, et al.
Published: (2019-07-01)

COMPLEX ASSESSMENT OF EFFICACY OF STATINS PRESCRIBED AT MOST BY CLINICIANS
by: A. S. Sivkov, et al.
Published: (2018-06-01)

Statin Intolerance and Adverse Effects in Lipid-Lowering Therapy – Pathomechanisms, Management Strategies, and Alternative Treatment Approaches
by: Natalia Śliwa, et al.
Published: (2025-06-01)

Statins: Evidence for effectiveness
by: K. Outhoff
Published: (2014-09-01)

The effects of statins on cytokines an endotelin-1 in patients with chronic obstructive pulmonary disease and diabetes mellitus
by: S. A. Nedomolkina, et al.
Published: (2021-06-01)

Moderate-intensity statin therapy. Efficacy and safety issues
by: N. G. Gogolashvili
Published: (2023-07-01)

Statins and diabetes mellitus: risks and benefits
by: O. M. Drapkina, et al.
Published: (2012-12-01)

APPROACHES TO STATIN THERAPY ADHERENCE IMPROVEMENT
by: S. A. Shalnova, et al.
Published: (2018-04-01)

Clinical efficacy and safety of statin treatment after carotid artery stenting
by: Lingya Qiao, et al.
Published: (2019-12-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

Statins associated diabetes: state of the problem in 2018
by: Zh. D. Kobalava, et al.
Published: (2018-09-01)

STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015-09-01)

Statins in arterial hypertension treatment
by: O. N. Tkacheva, et al.
Published: (1970-01-01)

STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY
by: Y. A. Karpov
Published: (2015-12-01)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS
by: E. I. Yakovenko, et al.
Published: (2012-04-01)

MICROCIRCULATORY ISCHEMIA AND STATINS: LESSONS OF INTERVENTION CARDIOLOGY
by: An. A. Alexandrov, et al.
Published: (2015-12-01)

Statin Therapy and Cognitive Impairment: Benefit or Harm?
by: O. D. Ostroumova, et al.
Published: (2018-09-01)

Statins and the risk of cataract
by: E. K. Butina, et al.
Published: (2019-12-01)

Statin treatment: myths and reality
by: L. A. Malay, et al.
Published: (2008-06-01)

Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)

STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01)

SHOULD STATINS BE DISCONTINUED IN PERI-OPERATIVE PERIOD?
by: V. V. Lomivorotov, et al.
Published: (2018-08-01)